tiprankstipranks
Trending News
More News >
Rallybio (RLYB)
NASDAQ:RLYB
US Market

Rallybio (RLYB) Income Statement

Compare
358 Followers

Rallybio Income Statement

Last quarter (Q3 2025), Rallybio's total revenue was $212.00K, a decrease of -29.10% from the same quarter last year. In Q3, Rallybio's net income was $16.02M. See Rallybio’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 636.00K$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ 636.00K$ 0.00$ 0.00$ 0.00$ 0.00
Operating Expenses
$ 61.13M$ 78.93M$ 67.88M$ 45.65M$ 25.30M
Depreciation and Amortization
$ 131.00K$ 150.00K$ 167.00K$ 109.00K$ 62.00K
EBITDA
$ -60.37M$ -78.78M$ -67.72M$ -45.39M$ -25.24M
Operating Income
$ -60.50M$ -78.93M$ -67.88M$ -45.65M$ -25.30M
Other Income/Expenses
$ 2.72M$ 4.37M$ 155.00K$ -1.36M$ -1.16M
Pretax Income
$ -57.77M$ -74.56M$ -67.73M$ -47.01M$ -26.46M
Net Income
$ -57.77M$ -74.56M$ -66.65M$ -47.01M$ -26.45M
Per Share Metrics
Basic EPS
$ -1.33$ -1.84$ -2.09$ -1.46$ -1.19
Diluted EPS
$ -1.33$ -1.84$ -2.09$ -1.46$ -1.19
Weighted Average Shares Outstanding
43.55M 40.45M 31.82M 32.13M 22.24M
Weighted Average Shares Outstanding (Diluted)
43.55M 40.45M 31.82M 32.13M 22.24M
Currency in USD

Rallybio Earnings and Revenue History